Serum HE4 and CA-125 as Combined Biomarkers for Early Diagnosis of  Ovarian Carcinoma

Saira Kiran, Rehana Batool, Habibah Nadeem, Hamna Rizwan, Shazia Hameed, Tahira Rizwan

Serum HE4 and CA-125 as Combined Biomarkers for Early Diagnosis of Ovarian Carcinoma

Authors

Saira Kiran, Rehana Batool, Habibah Nadeem, Hamna Rizwan, Shazia Hameed, Tahira Rizwan

Keywords:

HE4, CA-125, ovarian carcinoma, early detection.

Abstract

Early detection of epithelial ovarian carcinoma remains a major clinical challenge dueto its asymptomatic progression and lack of reliable single diagnostic biomarkers. This prospective case–control study evaluated

References

Gupta S, et al. Diagnostic performance of HE4 and CA-125 in differentiating ovarian malignancy. J Clin Med. 2021;10(18):4126

Downloads

Published

2025-11-13

How to Cite

Saira Kiran, Rehana Batool, Habibah Nadeem, Hamna Rizwan, Shazia Hameed, Tahira Rizwan. (2025). Serum HE4 and CA-125 as Combined Biomarkers for Early Diagnosis of Ovarian Carcinoma. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 3205–3211. Retrieved from https://ijprt.org/index.php/pub/article/view/1183